With the human health market being more mature and well-established, there is an opportunity to leverage these innovations to address unmet needs in the animal health sector. This session will focus on the possibilities that the translation between both spaces can offer.
What factors determine the translational potential of human health innovations to the animal health market? How to identify suitable assets and how to articulate the translation process? What are the key steps involved in adapting and validating human health innovations for animal health applications? What are the collaborative models and partnerships that facilitate the sourcing and translation of human health innovations for animal health? Who are the players scouting from human to animal health?
Moderator: Sven Arnouts, Business Development Manager, PROVAXS – Ghent University 
